HAS2 and glioblastoma: Unexpectedly, HAS2 overexpression in GBM cells abolished tumor formation in the brain in a mouse model; the authors proposed that this was due to a lack of HYAL activity, suggesting that gliomas may be more aggressive when coexpressing HAS and HYALs (215).